The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Metabolic genes in cancer: Their roles in tumor progression and clinical implications
Open accessAbstract
Re-programming of metabolic pathways is a hallmark of physiological changes in cancer cells. The expression of certain genes that directly control the rate of key metabolic pathways including glycolysis, lipogenesis and nucleotide synthesis are drastically altered at different stages of tumor progression. These alterations are generally considered as an adaptation of tumor cells; however, they also contribute to the progression of tumor cells to become more aggressive phenotypes. This review summarizes the recent information about the mechanistic link of these genes to oncogenesis and their potential utility as diagnostic markers as well as for therapeutic targets. We particularly focus on three groups of genes; GLUT1, G6PD, TKTL1 and PGI/AMF in glycolytic pathway, ACLY, ACC1 and FAS in lipogenesis and RRM1, RRM2 and TYMS for nucleotide synthesis. All these genes are highly up-regulated in a variety of tumor cells in cancer patients, and they play active roles in tumor progression rather than expressing merely as a consequence of phenotypic change of the cancer cells. Molecular dissection of their orchestrated networks and understanding the exact mechanism of their expression will provide a window of opportunity to target these genes for specific cancer therapy. We also reviewed existing database of gene microarray to validate the utility of these genes for cancer diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zhang, S., Yue, J.-X., Yang, J., Cai, P. C., & Kong, W. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.4.5479 · Cited by 26
RetractedUnderstanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
ATP-citrate lyase links cellular metabolism to histone acetylation
Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1164097 · Cited by 2,298
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1.
Semenza, G. L., Roth, P. H., Fang, H. M., & Wang, G. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31580-6 · Cited by 1,897
Semenza, G. L., Jiang, B.-H., Leung, S. W., Passantino, R., Concordet, J.-P., Maire, P., & Giallongo, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32529 · Cited by 1,752
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Cancer risk in mutation carriers of DNA-mismatch-repair genes
Aarnio, M., Sankila, R., Pukkala, E., Salovaara, R., Aaltonen, L. A., de la Chapelle, A., Peltom�ki, P., Mecklin, J.-P., & J�rvinen, H. J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990412)81:2<214::aid-ijc8>3.0.co;2-l · Cited by 1,278
Hypoxia-Inducible Factors, Stem Cells, and Cancer
Keith, B., & Simon, M. C. (2007) · Cell · doi:10.1016/j.cell.2007.04.019 · Cited by 1,179
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Zhao, S., Lin, Y., Xu, W., Jiang, W., Zha, Z., Wang, P., Yu, W., Li, Z., Gong, L., Peng, Y., et al. (2009) · Science · doi:10.1126/science.1170944 · Cited by 1,119
ATP citrate lyase inhibition can suppress tumor cell growth
Hatzivassiliou, G., Zhao, F., Bauer, D. E., Andreadis, C., Shaw, A. N., Dhanak, D., Hingorani, S. R., Tuveson, D. A., & Thompson, C. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.008 · Cited by 1,086
Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology
Kuhajda, F. P. (2000) · Nutrition · doi:10.1016/s0899-9007(99)00266-x · Cited by 788
Flier, J. S., Mueckler, M. M., Usher, P., & Lodish, H. F. (1987) · Science · doi:10.1126/science.3103217 · Cited by 786
Fatty acid synthesis: a potential selective target for antineoplastic therapy
Kuhajda, F. P., Jenner, K., Wood, F. D., Hennigar, R. A., Jacobs, L. B., Dick, J. D., & Pasternack, G. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6379 · Cited by 705 · cited 1×
“C75 was designed to be a less reactive (and therefore potentially safer) form of the classical FAS inhibitor, cerulenin (43).”
BackgroundMultifaceted roles of glycolytic enzymes
Kim, J.-W., & Dang, C. V. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.01.005 · Cited by 682
Glycolytic Enzymes Can Modulate Cellular Life Span
Kondoh, H., Lleonart, M. E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A., & Beach, D. (2005) · Cancer Research · doi:10.1158/0008-5472.177.65.1 · Cited by 647
Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity
Kridel, S. J., Axelrod, F., Rozenkrantz, N., & Smith, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3645 · Cited by 607
Ebert, B. L., Firth, J. D., & Ratcliffe, P. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29083 · Cited by 575
Creusot, F., Acs, G., & Christman, J. K. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68144-5 · Cited by 564
ATP citrate lyase is an important component of cell growth and transformation
Bauer, D. E., Hatzivassiliou, G., Zhao, F., Andreadis, C., & Thompson, C. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208773 · Cited by 537
Tumor cell autocrine motility factor.
Liotta, L. A., Mandler, R., Murano, G., Katz, D. A., Gordon, R. K., Chiang, P. K., & Schiffmann, E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3302 · Cited by 533
The Crystal Structure of a Mammalian Fatty Acid Synthase
Maier, T., Leibundgut, M., & Ban, N. (2008) · Science · doi:10.1126/science.1161269 · Cited by 505
Survival of Cancer Cells Is Maintained by EGFR Independent of Its Kinase Activity
Weihua, Z., Tsan, R., Huang, W.-C., Wu, Q., Chiu, C.-H., Fidler, I. J., & Hung, M.-C. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.03.015 · Cited by 490
Hypothalamic Fatty Acid Metabolism Mediates the Orexigenic Action of Ghrelin
López, M., Lage, R., Saha, A. K., Pérez-Tilve, D., Vázquez, M. J., Varela, L., Sangiao-Alvarellos, S., Tovar, S., Raghay, K., Rodríguez-Cuenca, S., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.006 · Cited by 468
Over-expression of facilitative glucose transporter genes in human cancer
Yamamoto, T., Seino, Y., Fukumoto, H., Koh, G., Yano, H., Inagaki, N., Yamada, Y., Inoue, K., Manabe, T., & Imura, H. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91263-r · Cited by 465
DNA Synthesis and Repair Genes RRM1 and ERCC1 in Lung Cancer
Zheng, Z., Chen, T., Li, X., Haura, E., Sharma, A., & Bepler, G. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065411 · Cited by 462
Guzy, R. D., Sharma, B., Bell, E., Chandel, N. S., & Schumacker, P. T. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01338-07 · Cited by 427
ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer
Migita, T., Narita, T., Nomura, K., Miyagi, E., Inazuka, F., Matsuura, M., Ushijima, M., Mashima, T., Seimiya, H., Satoh, Y., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1235 · Cited by 403
Architecture of Mammalian Fatty Acid Synthase at 4.5 Å Resolution
Maier, T., Jenni, S., & Ban, N. (2006) · Science · doi:10.1126/science.1123248 · Cited by 400
Furuta, E., Pai, S. K., Zhan, R., Bandyopadhyay, S., Watabe, M., Mo, Y.-Y., Hirota, S., Hosobe, S., Tsukada, T., Miura, K., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2489 · Cited by 392
Self-citationFatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer
Migita, T., Ruiz, S., Fornari, A., Fiorentino, M., Priolo, C., Zadra, G., Inazuka, F., Grisanzio, C., Palescandolo, E., Shin, E., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp030 · Cited by 387
Heidel, J. D., Yu, Z., Liu, J. Y.-C., Rele, S. M., Liang, Y., Zeidan, R. K., Kornbrust, D. J., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701458104 · Cited by 382
Swinnen, J. V., Roskams, T., Joniau, S., Van Poppel, H., Oyen, R., Baert, L., Heyns, W., & Verhoeven, G. (2002) · International Journal of Cancer · doi:10.1002/ijc.10127 · Cited by 381
Anderson, S. M., Rudolph, M. C., McManaman, J. L., & Neville, M. C. (2007) · Breast Cancer Research · doi:10.1186/bcr1653 · Cited by 380
Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements
Ramanathan, A., Wang, C., & Schreiber, S. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502267102 · Cited by 357
Acetyl-CoA Carboxylase α Is Essential to Breast Cancer Cell Survival
Chajès, V., Cambot, M., Moreau, K., Lenoir, G. M., & Joulin, V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1489 · Cited by 347
Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma.
Milgraum, L. Z., Witters, L. A., Pasternack, G. R., & Kuhajda, F. P. (1997) · PubMed · Cited by 333
Alo, P. L., Visca, P., Marci, A., Mangoni, A., Botti, C., & Di Tondo, U. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960201)77:3<474::aid-cncr8>3.0.co;2-k · Cited by 313
Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival
Gansler, T. S., Hardman, W., Hunt, D. A., Schaffel, S., & Hennigar, R. A. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90177-5 · Cited by 287
Transformation of Rat Fibroblasts by FSV Rapidly Increases Glucose Transporter Gene Transcription
Birnbaum, M. J., Haspel, H. C., & Rosen, O. M. (1987) · Science · doi:10.1126/science.3029870 · Cited by 281
Boros, L. G., Puigjaner, J., Cascante, M., Lee, W. N., Brandes, J. L., Bassilian, S., Yusuf, F., Williams, R. D., Muscarella, P., Melvin, W. S., et al. (1997) · PubMed · Cited by 277
(2001) · PubMed · Cited by 270
Godoy, A., Ulloa, V., Rodríguez, F., Reinicke, K., Yañez, A. J., García, M. D. L. A., Medina, R. A., Carrasco, M., Barberis, S., Castro, T., et al. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20606 · Cited by 270
Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.
Watanabe, H., TAKEHANA, K., Date, M., Shinozaki, T., & Raz, A. (1996) · PubMed · Cited by 268
Fong, Y., Saldinger, P. F., Akhurst, T., Macapinlac, H., Yeung, H., Finn, R. D., Cohen, A., Kemeny, N., Blumgart, L. H., & Larson, S. M. (1999) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)00187-7 · Cited by 267
Singh, D., Banerji, A. K., Dwarakanath, B. S., Tripathi, R. P., Gupta, J. P., Mathew, T. L., Ravindranath, T., & Jain, V. (2005) · Strahlentherapie und Onkologie · doi:10.1007/s00066-005-1320-z · Cited by 266
Rashid, A., Pizer, E. S., Moga, M., Milgraum, L. Z., Zahurak, M., Pasternack, G. R., Kuhajda, F. P., & Hamilton, S. R. (1997) · Europe PMC (PubMed Central) · Cited by 262
Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal
Abu-Elheiga, L., Matzuk, M. M., Kordari, P., Oh, W., Shaikenov, T., Gu, Z., & Wakil, S. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505714102 · Cited by 261
Langbein, S., Zerilli, M., zur Hausen, A., Staiger, W., Rensch-Boschert, K., Lukan, N., Popa, J., Ternullo, M. P., Steidler, A., Weiss, C., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602962 · Cited by 261
Ishii, T., Yasuda, K., Akatsuka, A., Hino, O., Hartman, P. S., & Ishii, N. (2005) · Cancer Research · doi:10.1158/0008-5472.203.65.1 · Cited by 253
Cytosolic NADP+-dependent Isocitrate Dehydrogenase Plays a Key Role in Lipid Metabolism
Koh, H.-J., Lee, S.-M., Son, B.-G., Lee, S.-H., Ryoo, Z. Y., Chang, K.-T., Park, J.-W., Park, D.-C., Song, B. J., Veech, R. L., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402260200 · Cited by 251
Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma
Yahagi, N., Shimano, H., Hasegawa, K., Ohashi, K., Matsuzaka, T., Najima, Y., Sekiya, M., Tomita, S., Okazaki, H., Tamura, Y., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.037 · Cited by 248
Chirala, S. S., Chang, H., Matzuk, M., Abu-Elheiga, L., Mao, J., Mahon, K., Finegold, M., & Wakil, S. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931394100 · Cited by 242
Gottlieb, R. A., Giesing, H. A., Zhu, J. Y., Engler, R. L., & Babior, B. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.13.5965 · Cited by 240
Simons, A. L., Ahmad, I. M., Mattson, D. M., Dornfeld, K. J., & Spitz, D. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3717 · Cited by 238
Xie, H., Valera, V. A., Merino, M. J., Amato, A. M., Signoretti, S., Linehan, W. M., Sukhatme, V. P., & Seth, P. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1049 · Cited by 233
Yoon, S., Lee, M.-Y., Park, S. W., Moon, J.-S., Koh, Y.-K., Ahn, Y.-H., Park, B.-W., & Kim, K.-S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702854200 · Cited by 224
Epstein, J. I., Carmichael, M., & Partin, A. W. (1995) · Urology · doi:10.1016/s0090-4295(95)96904-7 · Cited by 214
Shurbaji, M. S., Kalbfleisch, J. H., & Thurmond, T. S. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90218-x · Cited by 208
Vazquez‐Martin, A., Colomer, R., Brunet, J., Lupu, R., & Menendez, J. A. (2008) · Cell Proliferation · doi:10.1111/j.1365-2184.2007.00498.x · Cited by 199
Induction of Oxidative Metabolism by Mitochondrial Frataxin Inhibits Cancer Growth
Schulz, T. J., Thierbach, R., Voigt, A., Drewes, G., Mietzner, B., Steinberg, P., Pfeiffer, A. F. H., & Ristow, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511064200 · Cited by 197
Burant, C. F., & Bell, G. I. (1992) · Biochemistry · doi:10.1021/bi00157a032 · Cited by 197
Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation
Hatse, S., De Clercq, E., & Balzarini, J. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00035-0 · Cited by 189
The role of N-glycosylation of GLUT1 for glucose transport activity.
Asano, T., Katagiri, H., Takata, K., Lin, J. L., Ishihara, H., Inukai, K., Tsukuda, K., Kikuchi, M., Hirano, H., & Yazaki, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54276-9 · Cited by 187
Distribution of the glucose transporters in human brain tumors.
Nishioka, T., Oda, Y., Seino, Y., Yamamoto, T., Inagaki, N., Yano, H., Imura, H., Shigemoto, R., & Kikuchi, H. (1992) · PubMed · doi:10.11501/3066169 · Cited by 184
The effect of thiamine supplementation on tumour proliferation: A metabolic control analysis study
Comín‐Anduix, B., Boren, J., Martinez, S., Moro, C., Centelles, J. J., Trebukhina, R., Petushok, N., Lee, W. P., Boros, L. G., & Cascante, M. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02329.x · Cited by 181
Loss of the Mitochondrial Bioenergetic Capacity Underlies the Glucose Avidity of Carcinomas
López-Ríos, F., Sánchez-Aragó, M., García-García, E., Ortega, A. D., Berrendero, J. R., Pozo-Rodríguez, F., López-Encuentra, A., Ballestín, C., & Cuezva, J. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1678 · Cited by 180
Thymidylate synthase as an oncogene
Rahman, L., Voeller, D., Rahman, M., Lipkowitz, S., Allegra, C., Barrett, J. C., Kaye, F. J., & Zajac-Kaye, M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00080-7 · Cited by 178
Targets of gene amplification and overexpression at 17q in gastric cancer.
Varis, A., Wolf, M., Monni, O. M., Vakkari, M.-L., Kokkola, A., Moskaluk, C., Frierson, H. F., Powell, S. M., Knuutila, S., Kallioniemi, A. H., et al. (2002) · PubMed · Cited by 177
A catabolic block does not sufficiently explain how 2-deoxy-d-glucose inhibits cell growth
Ralser, M., Wamelink, M. M., Struys, E. A., Joppich, C., Krobitsch, S., Jakobs, C., & Lehrach, H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803090105 · Cited by 166
GLUT-1 expression in ovarian carcinoma: Association with survival and response to chemotherapy
Cantuaria, G., Fagotti, A., Ferrandina, G., Magalhaes, A., Nadji, M., Angioli, R., Penalver, M., Mancuso, S., & Scambia, G. (2001) · Cancer · doi:10.1002/1097-0142(20010901)92:5<1144::aid-cncr1432>3.0.co;2-t · Cited by 166
Tissue distribution of the human GLUT3 glucose transporter
Haber, R. S., Weinstein, S. P., O'Boyle, E., & Morgello, S. (1993) · Endocrinology · doi:10.1210/en.132.6.2538 · Cited by 165
ENZYMIC AND CEREBRAL METABOLIC EFFECTS OF 2‐DEOXY‐d‐GLUCOSE
Horton, R. W., Meldrum, B. S., & Bachelard, H. S. (1973) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1973.tb05996.x · Cited by 165
Mechanism of Apoptosis Induced by the Inhibition of Fatty Acid Synthase in Breast Cancer Cells
Bandyopadhyay, S., Zhan, R., Wang, Y., Pai, S. K., Hirota, S., Hosobe, S., Takano, Y., Saito, K., Furuta, E., Iiizumi, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3197 · Cited by 165
Self-citationKurtoglu, M., Maher, J. C., & Lampidis, T. J. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1714 · Cited by 163
Yang, Y. U.-A. N., Morin, P. J., Han, W. F., Chen, T., Bornman, D. M., Gabrielson, E. W., & Pizer, E. S. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00023-x · Cited by 159
Fatty acid synthase expression in melanoma
Innocenzi, D., Alò, P. L., Balzani, A., Sebastiani, V., Silipo, V., La Torre, G., Ricciardi, G., Bosman, C., & Calvieri, S. (2003) · Journal of Cutaneous Pathology · doi:10.1034/j.1600-0560.2003.300104.x · Cited by 159
THE EFFECT OF 2-DEOXY-D-GLUCOSE INFUSIONS ON LIPID AND CARBOHYDRATE METABOLISM IN MAN*
László, J., Harlan, W. R., Klein, R. F., et al. (1961) · Journal of Clinical Investigation · doi:10.1172/jci104232 · Cited by 159
Piyathilake, C. J., Frost, A. R., Manne, U., Bell, W. C., Weiss, H. L., Heimburger, D. C., & Grizzle, W. E. (2000) · Human Pathology · doi:10.1053/hupa.2000.9842 · Cited by 157
Role for glucose transporter 1 protein in human breast cancer
Grover‐McKay, M., Walsh, S. A., Seftor, E. A., THOMAS, P. A., & Hendrix, M. J. C. (1998) · Pathology & Oncology Research · doi:10.1007/bf02904704 · Cited by 153
Xu, X., Hausen, A. Z., Coy, J. F., & Löchelt, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.24078 · Cited by 151
Energy metabolism transition in multi‐cellular human tumor spheroids
Rodríguez‐Enríquez, S., Gallardo‐Pérez, J. C., Avilés‐Salas, A., Marín‐Hernández, Á., Carreño‐Fuentes, L., Lagunas, V. M., & Moreno‐Sánchez, R. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21392 · Cited by 147
Kuo, W.-Y., Lin, J.-Y., & Tang, T. K. (2000) · International Journal of Cancer · Cited by 146
RRM1-induced metastasis suppression through PTEN-regulated pathways
Gautam, A., Li, Z.-R., & Bepler, G. (2003) · Oncogene · doi:10.1038/sj.onc.1206232 · Cited by 146
Role of ribonucleotide reductase in expression of the neoplastic program
Takeda, E., & Weber, G. F. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90746-3 · Cited by 137
Kusakabe, T., Nashimoto, A., Honma, K., & Suzuki, T. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.01289.x · Cited by 136
Long-Term Effects of Increased Glucose Entry on Mouse Hearts During Normal Aging and Ischemic Stress
Luptak, I., Yan, J., Cui, L., Jain, M., Liao, R., & Tian, R. (2007) · Circulation · doi:10.1161/circulationaha.107.691253 · Cited by 126
Prognostic importance of thymidylate synthase expression in early breast cancer.
Pestalozzi, B. C., Peterson, H. F., Gelber, R. D., Goldhirsch, A., Gusterson, B. A., Trihia, H., Lindtner, J., Cortés-Funes, H., Simmoncini, E., Byrne, M., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.1923 · Cited by 123
Bandyopadhyay, S., Pai, S. K., Watabe, M., Gross, S. C., Hirota, S., Hosobe, S., Tsukada, T., Miura, K., Saito, K., Markwell, S. J., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208555 · Cited by 123
Self-citationMetastasis is promoted by a bioenergetic switch: New targets for progressive renal cell cancer
Langbein, S., Frederiks, W. M., Hausen, A. Z., Popa, J., Lehmann, J., Weiß, C., Alken, P. M., & Coy, J. F. (2008) · International Journal of Cancer · doi:10.1002/ijc.23403 · Cited by 121
Wang, Y. (., Kuhajda, F. P., Li, J. N., Pizer, E. S., Han, W. F., Sokoll, L. J., & Chan, D. W. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00464-5 · Cited by 116
Differentiation of human tumors from nonmalignant tissue by natural‐abundance 13C NMR spectroscopy
Halliday, K. R., Fenoglio‐Preiser, C., & Sillerud, L. O. (1988) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910070403 · Cited by 116
Glut1 expression in T1 and T2 stage colorectal carcinomas
Sakashita, M., Aoyama, N., Minami, R., Maekawa, S., Kuroda, K., Shirasaka, D., Ichihara, T., Kuroda, Y., Maeda, S., & Kasuga, M. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00371-3 · Cited by 107
Szutowicz, A., Kwiatkowski, J., & Angielski, S. (1979) · British Journal of Cancer · doi:10.1038/bjc.1979.120 · Cited by 107
Nagase, Y., Takata, K., Moriyama, N., Aso, Y., Murakami, T., & Hirano, H. (1995) · The Journal of Urology · doi:10.1097/00005392-199503000-00077 · Cited by 107
Zhou, B.-S., Tsai, P., Ker, R., Tsai, J., Ho, R., Yu, J., Shih, J., & Yen, Y. (1998) · Clinical & Experimental Metastasis · doi:10.1023/a:1006559901771 · Cited by 104
Santamaria-Nuñez, G., Martínez, M., Fabregat, I., & Cuezva, J. M. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi315 · Cited by 102
Zhang, K., Hu, S., Wu, J., Chen, L., Lu, J., Wang, X., Liu, X., Zhou, B., & Yen, Y. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-11 · Cited by 101
Increased cytidine 5'-triphosphate synthetase activity in rat and human tumors.
Kizaki, H., Williams, J. C., Morris, H. P., & Weber, G. F. (1980) · PubMed · Cited by 100
Fan, H., Huang, A., Villegas, C., & Wright, J. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13181 · Cited by 100
Yin, H.-Q., Kim, M., Kim, J. H., Kong, G., Kang, K., Kim, H., Yoon, B.-I., Lee, M., & Lee, B. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.06.018 · Cited by 99
Broad Overexpression of Ribonucleotide Reductase Genes in Mice Specifically Induces Lung Neoplasms
Xu, X., Page, J. L., Surtees, J. A., Liu, H., Lagedrost, S. J., Lu, Y., Bronson, R. T., Alani, E., Nikitin, A. Y., & Weiss, R. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5873 · Cited by 93
Turyn, J., Schlichtholz, B., Dettlaff‐Pokora, A., Presler, M., Goyke, E., Matuszewski, M., Kmieć, Z., Krajka, K., & Świerczyński, J. (2003) · Hormone and Metabolic Research · doi:10.1055/s-2003-43500 · Cited by 92
RRM2 induces NF-κB-dependent MMP-9 activation and enhances cellular invasiveness
Duxbury, M. S., & Whang, E. E. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.177 · Cited by 91
Lee, Y., Vassilakos, A., Feng, N., Lam, V., Xie, H., Wang, M., Jin, H., Xiong, K., Liu, C., Wright, J., et al. (2003) · PubMed · Cited by 91
Effects of Thiamine Deficiency and of Oxythiamine on Rat Tissue Transketolase
Brin, M. (1962) · Journal of Nutrition · doi:10.1093/jn/78.2.179 · Cited by 88
Choi, W.-I., Jeon, B.-N., Park, H., Yoo, J.-Y., Kim, Y., Koh, D., Kim, M.-H., Kim, Y.-R., Lee, C.-E., Kim, K.-S., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802477200 · Cited by 88
Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia
Wang, B. Y., Kalir, T., Sabo, E., Sherman, D. E., Cohen, C. J., & Burstein, D. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12<2774::aid-cncr16>3.0.co;2-i · Cited by 84
Nagase, Y., Takata, K., Moriyama, N., Aso, Y., Murakami, T., & Hirano, H. (1995) · The Journal of Urology · doi:10.1016/s0022-5347(01)67725-5 · Cited by 82
Autocrine Motility Factor Signaling Enhances Pancreatic Cancer Metastasis
Tsutsumi, S., Yanagawa, T., Shimura, T., Kuwano, H., & Raz, A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1015 · Cited by 81
Suppression of Lung Tumor Formation by the Regulatory Subunit of Ribonucleotide Reductase
Gautam, A., & Bepler, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4462 · Cited by 80
Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma
Sebastiani, V. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.10.027 · Cited by 75
Krockenberger, M., Hönig, A., Rieger, L., Coy, J. F., Sütterlin, M., Kapp, M., Horn, E., Dietl, J., & Kämmerer, U. (2007) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2007.00799.x · Cited by 73
Hu, L., Yang, J., De-tai, Z., Zhang, S., Wang, L., Cai, P., Zheng, J., & Huang, J. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328013d99e · Cited by 71
Funasaka, T., Hu, H., Yanagawa, T., Hogan, V. A., & Raz, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3935 · Cited by 70
GLUT1 Messenger RNA and Protein Induction Relates to the Malignant Transformation of Cervical Cancer
Rudlowski, C., Becker, A. J., Schroder, W., et al. (2003) · American Journal of Clinical Pathology · doi:10.1309/4kyn-qm58-62jw-2gd7 · Cited by 69
Radiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cells
Varshney, R. K., Dwarakanath, B. S. R., & Jain, V. (2005) · International Journal of Radiation Biology · doi:10.1080/09553000500148590 · Cited by 65
Chang, L., Zhou, B., Hu, S., Guo, R., Liu, X., Jones, S. N., & Yen, Y. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803313105 · Cited by 64
Ogawa, J., Inoue, H. K., & Koide, S. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970422)74:2<189::aid-ijc9>3.0.co;2-v · Cited by 62
Conde, E., Suárez‐Gauthier, A., García-García, E., López‐Ríos, F., Encuentra, Á. L., García‐Luján, R., Morente, M. M., Sánchez-Verde, L., & Sánchez‐Céspedes, M. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.01.022 · Cited by 59
Expression of Autocrine Motility Factor (AMF) and Its Receptor, AMFR, in Human Breast Cancer
Jiang, W. G., Raz, A., Douglas-Jones, A. G., & Mansel, R. E. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6785.2005 · Cited by 59
Proteomic analysis of protein expression in prostate cancer.
Lexander, H., Palmberg, C., Auer, G., Hellström, M., Franzén, B., Jörnvall, H., & Egevad, L. (2005) · PubMed · Cited by 57
Expression of the human erythrocyte glucose transporter Glut1 in cutaneous neoplasia
Baer, S. C., Casaubonb, L., & Younes, M. (1997) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(97)70174-9 · Cited by 56
Dong, S., Lester, L., & Johnson, L. F. (2000) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(20000401)77:1<50::aid-jcb6>3.0.co;2-c · Cited by 54
Sahla, M. E., Thézenas, S., Simony-Lafontaine, J., Kramar, A., Lavaill, R., Chalbos, D., & Rochefort, H. (2006) · International Journal of Cancer · doi:10.1002/ijc.22202 · Cited by 53
Regulation of p53R2 and its role as potential target for cancer therapy
Wang, X., Zhenchuk, A., Wiman, K. G., & Albertioni, F. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.07.019 · Cited by 48
The value of tumour markers in lung cancer
Gomm, S., Keevil, B. G., Thatcher, N., Hasleton, P. S., & Swindell, R. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.312 · Cited by 47
Yanagawa, T., Watanabe, H., Takeuchi, T., et al. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700057 · Cited by 47
Song, I.-S., Wang, A.-G., Yoon, S. Y., Kim, J., Kim, J. H., Lee, D., & Kim, N. S. (2009) · Experimental & Molecular Medicine · doi:10.3858/emm.2009.41.1.007 · Cited by 45
Xue, L., Zhou, B., Liu, X., Heung, Y. J., Chau, J., Chu, E., Li, S., Jiang, C., Un, F., & Yen, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3200 · Cited by 44
Funasaka, T., Hu, H., Hogan, V. A., & Raz, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706301200 · Cited by 34
Younes, M., Ertan, A., Lechago, L. V., Somoano, J. R., & Lechago, J. (1997) · PubMed · Cited by 32
Ribonucleotide reductase small subunit p53R2 suppresses MEK–ERK activity by binding to ERK kinase 2
Piao, C., Jin, M., Kim, H. B., Lee, S. M., Amatya, P., Hyun, J. W., Chang, I. Y., & You, H. J. (2009) · Oncogene · doi:10.1038/onc.2009.84 · Cited by 31
Chen, M., Rahman, L., Voeller, D. M., Kastanos, E. K., Yang, S. X., Feigenbaum, L., Allegra, C. J., Kaye, F. J., Steeg, P. S., & Zajac‐Kaye, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210273 · Cited by 27
Arczewska, K. D., & Kuśmierek, J. T. (2007) · Acta Biochimica Polonica · doi:10.18388/abp.2007_3220 · Cited by 23
Bianchi, A., Evans, J. L., Nordlund, A. C., Watts, T. D., & Witters, L. A. (1992) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240480113 · Cited by 19
(1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0142(19980701)83:1 · Cited by 3
Overexpression of glut-1 glucose transporter in human breast cancer an immunohistochemical study
(1993) · doi:10.1002/1097-0142(19931115)72:10 · Cited by 1
Cited by
Targeting cancer metabolism: a therapeutic window opens
Vander Heiden, M. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,411
Pancancer survival analysis of cancer hallmark genes
Nagy, Á., Munkácsy, G., & Győrffy, B. (2021) · Scientific Reports · doi:10.1038/s41598-021-84787-5 · Cited by 1,381
ATP-Citrate Lyase: A Key Player in Cancer Metabolism
Zaidi, N., Swinnen, J. V., & Smans, K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4112 · Cited by 545
Tamada, M., Nagano, O., Tateyama, S., Ohmura, M., Yae, T., Ishimoto, T., Sugihara, E., Onishi, N., Yamamoto, T., Yanagawa, H., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3024 · Cited by 275
Zaytseva, Y. Y., Rychahou, P. G., Gulhati, P., Elliott, V. A., Mustain, W. C., O'Connor, K., Morris, A. J., Sunkara, M., Weiss, H. L., Lee, E. Y., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4057 · Cited by 208
Metadata
- Authors
- Furuta, E., Okuda, H., Kobayashi, A., & Watabe, K.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 1805
- Issue
- 2
- Pages
- 141-152
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W2049775573
- Cited by
- 282
- References
- 146
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.